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Primary sarcomas of the pancreas are extremely rare, accounting for 0.1% of malignant pancreatic (non-islet) neoplasms. 
Pancreatic leiomyosarcoma is a highly aggressive malignancy that spreads in a similar manner to gastric leiomyosarcoma, 
i.e., by adjacent organ invasion, hematogenous spread, and lymph node metastasis. These tumors are large at the time of di-
agnosis and are usually found at an advanced stage. We report a case of a 70-year-old female with intermittent right upper 
quadrant abdominal discomfort. Radiological, histopathological, and immunohistochemical studies revealed the tumor to be 
a primary leiomyosarcoma of the pancreas. Herein, we describe a patient with a primary leiomyosarcoma of the pancreas 
who presented with clinical and radiological findings indicative of a mass in the pancreatic head.
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INTRODUCTION
Most of the malignant tumors of the pancreas are ad-
enocarcinomas arising from the ductal epithelium. 
Although a primary pancreatic leiomyosarcoma is the most 
common sarcoma of the pancreas, it is rare and accounts for 
only 0.1% of malignant pancreatic cancers [1]. Since 1951, 
when Rose [2] presented the first case, less than 50 cases 
have been reported in the English literature [3-5]. In the 
Korean literature, only one case has been reported until 
now [6]. The majority of the reported cases are diagnosed 
on autopsy. Herein, we present a case of primary pancreatic 
leiomyosarcoma occurring in a 70-year-old female.
CASE REPORT
A 70-year-old woman presented with intermittent right 
upper quadrant abdominal discomfort. Her complaints 
had been intermittently present for several months before 
admission. She was recently diagnosed with hyperten-
sion. A physical examination revealed no characteristic 
features. Abdominal computed tomography (CT) revea-
led a 4.5 × 5 cm heterogeneous enhancing mass arising 
from the pancreatic head (Fig. 1A, B). A magnetic reso-
nance imaging (MRI) scan of the pancreas showed a 5.3 × 
4 cm heterogenously enhanced mass that was abutting to 
the superior mesenteric vein and inferior vena cava (IVC) Young Hoe Hur, et al.
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Fig. 2. Whole body [
18F]- 
fluoro-deoxy glucose 
positron emission tomo-
graphy/computed to-
mography demonstra-
tes a 5.6 × 3.8 cm size 
hypermetabolic mass 
arising from the pan-
creatic head in the re-
tropancreatic space.
Fig. 1. Abdominal com-
puted tomography (CT) 
scan shows growth of 
the tumor, which is hete-
rogeneously enhanced 
by contrast media (A, 
white arrow). CT scan 
shows the tumor, which 
is abutting to the infe-
rior vena cava (B, black 
arrow). Magnetic reso-
nance imaging shows a 
5.3 × 4 cm heteroge-
nously enhanced mass 
(C, D).
(Fig. 1C, D). No focal enhancing mass was observed in the 
liver, and there was an enlarged lymph node in the ab-
dominal cavity. Whole body [
18F]-fluoro-deoxy glucose 
positron emission tomography (PET)/CT demonstrated a 
5.6 × 3.8 cm sized hypermetabolic mass arising from the 
pancreatic head in the retropancreatic space (Fig. 2). 
Laboratory data revealed that renal function was normal 
and tumor markers (carcinoembryonic antigen and carbo-
hydrate antigen 19-9) were normal. The initial diagnosis 
was pancreatic head cancer or a neuroendocrine tumor of 
the pancreas. On laparotomy, a 5 × 5 cm multiseptated 
mass had adhered to the IVC and left renal vein without 
evidence of peritoneal dissemination or hepatic metastasis. 
A pylorus-preserving pancreaticoduodenectomy with re-
gional lymph node dissection was performed. Macroscop-
ically, the mass had arisen from the pancreatic head and 
was limited to the pancreas. The cut surface of the tumor 
was whitish and showed signs of internal hemorrhage and 
partial myxoid change (Fig. 3A). Microscopically, nuclear 
atypia and pleomorphism were marked in the more dense Primary leiomyosarcoma of the pancreas
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Fig. 3. The gross pathological examination reveals a 5 × 5 cm multiseptated mass in the pancreatic head. The cut surface of the tumor is whitish 
and shows signs of internal hemorrhage and partial myxoid change (A). Interface of tumor (left) and compressed adjacent pancreatic tissue 
with fibrosis (B, H&E, ×40). The mass contains interlacing spindle-shaped cells with varying degrees of pleomorphism and atypia (C, H&E, 
×200). The immunohistochemical findings show strong immunoreactivity of the tumor cells to actin (D, labeled streptavidin-biotin, original 
magnification ×200).
cellular area, where frequent mitotic figures (up to 10 mi-
toses per 10 high-power fields [HPFs]) could be identified 
(Fig. 3B, C). The resected peripancreatic lymph node and 
surgical margins were free of tumor. A immunohisto-
chemical examination showed positive staining for actin 
(Fig. 3D), vimentin, and focal staining for desmin. 
However, CK, S-100, CD34, c-kit, and myogenin were 
negative. Finally, the tumor was diagnosed as a primary 
leiomyosarcoma of the pancreas.
The patient was discharged on postoperative day 22 
with an uneventful recovery. Six months later, a follow-up 
enhanced abdominal CT scan revealed multiple irregular 
ill-defined metastatic lesions in the liver, a 2.6 cm enhanc-
ing nodule invading the inferior vena cava in the aorto-
caval space, and focal thrombi in IVC. She refused any ad-
ditional adjuvant chemotherapy and had received pallia-
tive radiotherapy. However, she was re-admitted due to 
aggravation of hepatic metastasis and tumoral thrombi in 
IVC with obstruction, and died 22 months after the 
surgery.
DISCUSSION
Leiomyosarcomas involving the pancreas consist of a 
primary pancreatic leiomyosarcoma or pancreatic ex-
tensions of a retroperitoneal and gastroduodenal sarcoma 
[1]. Leiomyosarcomas originating from other organs such 
as the stomach, duodenum, and retroperitoneal organs of-
ten invade the pancreas, simulating a primary tumor of 
the pancreas. Therefore, to diagnose a primary leiomyo-
sarcoma of the pancreas, it is essential to rule out a tumor 
arising from other surrounding organs [3]. In the present 
case, the tumor was predominantly located in the head of Young Hoe Hur, et al.
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the pancreas, and the CT scan, MRI, whole body PET/CT, 
and operative findings showed no evidence of a mass orig-
inating from any other adjacent organs. The pancreatic 
origin of the leiomyosarcoma was thus confirmed.
A pancreatic leiomyosarcoma is more common in the 
fifth decade of life or older (mean age, 44.7 years; range, 14 
to 80 years). Males are affected almost twice as much as fe-
males (7:4). The size of tumors is rather variable ranging 
from 3 to 25 cm (median, 10.5 cm) [5]. Larger tumors can 
develop cystic degeneration and can be misdiagnosed as 
pseudocysts of the pancreas [7].
Abdominal pain, weight loss, epigastric tenderness, 
and an abdominal mass are the most commonly present-
ing symptoms [7], but these are nonspecific. Imaging stud-
ies can also be nonspecific [8]. Abdominal CT scans have 
revealed solid, cystic and heterogenous images dis-
tributed along the pancreatic head, body, and tail [8], and 
angiography, ultrasound, endoscopic ultrasound and MRI 
are all useful diagnostic imaging methods.
In general, leiomyosarcomas of the pancreas present as 
large cystic structures. Cystic changes are often associated 
with hemorrhage or necrosis and may represent degener-
ative change in a rapidly enlarging solid tumor. Histologi-
cally, most tumors showed aggressive features of high cel-
lularity, pleomorphism, and a substantial number of mi-
tosis [4].
An immunohistochemical examination is important for 
an accurate diagnosis. The diagnosis is based mainly on 
immunohistochemical characteristics, including expre-
ssion of specific marker proteins. Stromal tumors are usu-
ally diagnosed as myogenic (i.e., leiomyomas or leiomyo-
sarcomas) when they are diffusely positive for desmin or 
smooth muscle action, as neurogenic when positive for the 
S-100 protein, or as gastrointestinal stromal tumors (GIST) 
when positive for CD117 (c-kit) [9]. Vimentin is not consid-
ered specific because this marker protein may be ex-
pressed in GIST, myogenic tumors, or neurogenic tumors. 
In our case, the tumor was positive for actin, desmin 
(focal), and negative for S-100, CD34, c-kit, indicating im-
munohistochemical features compatible with leiomyo-
sarcoma.
A pancreatic leiomyosarcoma is a highly aggressive ma-
lignancy that spreads by adjacent organ direct invasion, 
hematogenous spread, and lymph node metastasis. In ad-
dition, these tumors are usually discovered at an ad-
vanced stage and have a propensity to invade the sur-
rounding organs and vessels. Therefore, an extended re-
section such as a pancreatoduodenectomy (for lesions of 
the head) or a distal pancreatectomy with a splenectomy 
(for lesions of the body and tail) has been advocated. 
Complete surgical resection offers the only potential 
chance of cure for patients with a leiomyosarcoma of the 
pancreas [3]. As with other leiomyosarcomas, radiation 
and chemotherapy have met with minimal clinical 
success.
Large tumor size is not a precise predictor of adverse 
outcome. In leiomyomatous tumors, mitotic figures have 
been suggested to be the most important predicting pa-
rameter [10]. Mitotic counts of more than 10 mitoses/10 
HPFs are associated with a worse outcome [1].
In summary, a primary leiomyosarcoma of the pancreas 
is extremely rare. Most pancreatic stromal tumors are 
GISTs or neurogenic tumors. The diagnosis of pancreatic 
leiomyosarcoma is confirmed by ruling out a tumor aris-
ing from other surrounding organs (i.e., stomach, duode-
num, and other retroperitoneal organs). A detailed clinical 
evaluation and awareness of primary pancreatic leiomyo-
sarcoma will be helpful to distinguish this malignant tu-
mor from other stromal tumors originating from other 
organs.
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